Indigo Diabetes nets Series B
Indigo Diabetes, a developer of a glucose monitoring device for diabetics, has secured 38 million euros in Series B funding.
Indigo Diabetes, a developer of a glucose monitoring device for diabetics, has secured 38 million euros in Series B funding.
Copyright PEI Media
Not for publication, email or dissemination
